| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 1.80e-12 | 5 | 17 | 4 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 1.26e-11 | 7 | 17 | 4 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 1.26e-11 | 7 | 17 | 4 | GO:0018685 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 7.52e-11 | 10 | 17 | 4 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 7.52e-11 | 10 | 17 | 4 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 7.52e-11 | 10 | 17 | 4 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 2.56e-10 | 13 | 17 | 4 | GO:0016713 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 3.78e-09 | 24 | 17 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 6.23e-09 | 27 | 17 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.85e-08 | 35 | 17 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 3.22e-08 | 40 | 17 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 7.44e-08 | 49 | 17 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | arachidonate binding | 2.32e-07 | 15 | 17 | 3 | GO:0050544 | |
| GeneOntologyMolecularFunction | icosanoid binding | 2.85e-07 | 16 | 17 | 3 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 2.85e-07 | 16 | 17 | 3 | GO:0050543 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 6.82e-07 | 2 | 17 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 6.82e-07 | 2 | 17 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 1.66e-06 | 28 | 17 | 3 | GO:0036041 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 2.34e-06 | 115 | 17 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | heme binding | 7.49e-06 | 154 | 17 | 4 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 9.60e-06 | 164 | 17 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.01e-05 | 166 | 17 | 4 | GO:0005506 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.86e-05 | 194 | 17 | 4 | GO:0016705 | |
| GeneOntologyMolecularFunction | fatty acid binding | 2.59e-05 | 69 | 17 | 3 | GO:0005504 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 9.63e-05 | 107 | 17 | 3 | GO:0033293 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.02e-03 | 239 | 17 | 3 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.21e-03 | 254 | 17 | 3 | GO:0043177 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 3.43e-03 | 766 | 17 | 4 | GO:0016491 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 6.02e-03 | 138 | 17 | 2 | GO:0016614 | |
| GeneOntologyMolecularFunction | lipid binding | 8.45e-03 | 988 | 17 | 4 | GO:0008289 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.60e-02 | 1189 | 17 | 4 | GO:0046914 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 3.62e-12 | 6 | 16 | 4 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 8.44e-12 | 7 | 16 | 4 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 1.69e-11 | 8 | 16 | 4 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 7.94e-11 | 11 | 16 | 4 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 1.19e-10 | 12 | 16 | 4 | GO:0042758 | |
| GeneOntologyBiologicalProcess | menaquinone catabolic process | 3.83e-10 | 3 | 16 | 3 | GO:0042361 | |
| GeneOntologyBiologicalProcess | menaquinone metabolic process | 1.53e-09 | 4 | 16 | 3 | GO:0009233 | |
| GeneOntologyBiologicalProcess | phylloquinone metabolic process | 1.53e-09 | 4 | 16 | 3 | GO:0042374 | |
| GeneOntologyBiologicalProcess | phylloquinone catabolic process | 1.53e-09 | 4 | 16 | 3 | GO:0042376 | |
| GeneOntologyBiologicalProcess | vitamin K catabolic process | 1.53e-09 | 4 | 16 | 3 | GO:0042377 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 1.75e-09 | 22 | 16 | 4 | GO:1901569 | |
| GeneOntologyBiologicalProcess | prostaglandin catabolic process | 7.65e-09 | 6 | 16 | 3 | GO:1905344 | |
| GeneOntologyBiologicalProcess | prostanoid catabolic process | 7.65e-09 | 6 | 16 | 3 | GO:0062232 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 2.40e-08 | 41 | 16 | 4 | GO:0006691 | |
| GeneOntologyBiologicalProcess | vitamin K metabolic process | 6.30e-08 | 11 | 16 | 3 | GO:0042373 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin catabolic process | 8.39e-08 | 12 | 16 | 3 | GO:0042363 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 1.39e-07 | 14 | 16 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 1.91e-07 | 68 | 16 | 4 | GO:0019369 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 2.54e-07 | 73 | 16 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | vitamin catabolic process | 3.10e-07 | 18 | 16 | 3 | GO:0009111 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 4.07e-07 | 82 | 16 | 4 | GO:1901568 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 5.05e-07 | 21 | 16 | 3 | GO:0042182 | |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 1.64e-06 | 116 | 16 | 4 | GO:0009062 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid metabolic process | 2.14e-06 | 124 | 16 | 4 | GO:0001676 | |
| GeneOntologyBiologicalProcess | unsaturated fatty acid metabolic process | 2.43e-06 | 128 | 16 | 4 | GO:0033559 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 3.67e-06 | 142 | 16 | 4 | GO:0006690 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid catabolic process | 3.99e-06 | 145 | 16 | 4 | GO:0072329 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin metabolic process | 7.80e-06 | 51 | 16 | 3 | GO:0006775 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 7.84e-06 | 382 | 16 | 5 | GO:0016042 | |
| GeneOntologyBiologicalProcess | vitamin E metabolic process | 8.45e-06 | 6 | 16 | 2 | GO:0042360 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 9.41e-06 | 180 | 16 | 4 | GO:0120254 | |
| GeneOntologyBiologicalProcess | organic acid catabolic process | 4.75e-05 | 272 | 16 | 4 | GO:0016054 | |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | 4.75e-05 | 272 | 16 | 4 | GO:0046395 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 9.38e-05 | 641 | 16 | 5 | GO:1901615 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 1.29e-04 | 22 | 16 | 2 | GO:0019373 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 1.38e-04 | 133 | 16 | 3 | GO:0006766 | |
| GeneOntologyBiologicalProcess | regulation of glial cell migration | 2.26e-04 | 29 | 16 | 2 | GO:1903975 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 2.56e-04 | 421 | 16 | 4 | GO:0044282 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 2.68e-04 | 802 | 16 | 5 | GO:0048812 | |
| GeneOntologyBiologicalProcess | neuron projection development | 2.69e-04 | 1285 | 16 | 6 | GO:0031175 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 2.95e-04 | 819 | 16 | 5 | GO:0120039 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 3.07e-04 | 826 | 16 | 5 | GO:0048858 | |
| GeneOntologyBiologicalProcess | very long-chain fatty acid metabolic process | 3.31e-04 | 35 | 16 | 2 | GO:0000038 | |
| GeneOntologyBiologicalProcess | fatty acid metabolic process | 3.62e-04 | 461 | 16 | 4 | GO:0006631 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 5.07e-04 | 207 | 16 | 3 | GO:1990138 | |
| GeneOntologyBiologicalProcess | neuron development | 5.43e-04 | 1463 | 16 | 6 | GO:0048666 | |
| GeneOntologyBiologicalProcess | positive regulation of cell growth | 5.51e-04 | 213 | 16 | 3 | GO:0030307 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 7.60e-04 | 238 | 16 | 3 | GO:0048639 | |
| GeneOntologyBiologicalProcess | positive regulation of axon extension | 8.18e-04 | 55 | 16 | 2 | GO:0045773 | |
| GeneOntologyBiologicalProcess | ketone metabolic process | 1.20e-03 | 279 | 16 | 3 | GO:0042180 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA metabolic process | 1.44e-03 | 73 | 16 | 2 | GO:2000630 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 1.47e-03 | 299 | 16 | 3 | GO:0060560 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 1.50e-03 | 301 | 16 | 3 | GO:0048588 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 1.65e-03 | 1194 | 16 | 5 | GO:0000902 | |
| GeneOntologyBiologicalProcess | glial cell migration | 1.72e-03 | 80 | 16 | 2 | GO:0008347 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 2.03e-03 | 731 | 16 | 4 | GO:0032787 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | 2.04e-03 | 1253 | 16 | 5 | GO:0044248 | |
| GeneOntologyBiologicalProcess | positive regulation of growth | 2.10e-03 | 339 | 16 | 3 | GO:0045927 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 2.27e-03 | 92 | 16 | 2 | GO:0048844 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 2.38e-03 | 354 | 16 | 3 | GO:0050769 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid transport | 2.78e-03 | 102 | 16 | 2 | GO:0032370 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 2.83e-03 | 103 | 16 | 2 | GO:2000628 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 2.89e-03 | 104 | 16 | 2 | GO:0030516 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 3.45e-03 | 114 | 16 | 2 | GO:0050772 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 3.76e-03 | 119 | 16 | 2 | GO:0010586 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 3.80e-03 | 418 | 16 | 3 | GO:0051962 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 3.88e-03 | 421 | 16 | 3 | GO:0048638 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 3.94e-03 | 122 | 16 | 2 | GO:0061387 | |
| GeneOntologyBiologicalProcess | gliogenesis | 4.25e-03 | 435 | 16 | 3 | GO:0042063 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid localization | 4.40e-03 | 129 | 16 | 2 | GO:1905954 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 4.45e-03 | 442 | 16 | 3 | GO:0050878 | |
| GeneOntologyCellularComponent | apical part of cell | 6.04e-05 | 592 | 16 | 5 | GO:0045177 | |
| GeneOntologyCellularComponent | apical plasma membrane | 4.24e-04 | 487 | 16 | 4 | GO:0016324 | |
| GeneOntologyCellularComponent | axonal growth cone | 5.33e-04 | 45 | 16 | 2 | GO:0044295 | |
| GeneOntologyCellularComponent | growth cone | 7.96e-04 | 245 | 16 | 3 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 8.73e-04 | 253 | 16 | 3 | GO:0030427 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 2.21e-03 | 1293 | 16 | 5 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 2.25e-03 | 1299 | 16 | 5 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 2.48e-03 | 1327 | 16 | 5 | GO:0042175 | |
| GeneOntologyCellularComponent | distal axon | 4.10e-03 | 435 | 16 | 3 | GO:0150034 | |
| HumanPheno | Subretinal fluid | 7.25e-05 | 10 | 7 | 2 | HP:0031526 | |
| HumanPheno | Periauricular skin pits | 7.33e-05 | 67 | 7 | 3 | HP:0100277 | |
| HumanPheno | Branchial anomaly | 1.16e-04 | 78 | 7 | 3 | HP:0009794 | |
| HumanPheno | Skin pit | 1.44e-04 | 84 | 7 | 3 | HP:0100276 | |
| HumanPheno | Localized skin lesion | 1.75e-04 | 897 | 7 | 6 | HP:0011355 | |
| HumanPheno | Narrow face | 3.05e-04 | 108 | 7 | 3 | HP:0000275 | |
| HumanPheno | Bicuspid aortic valve | 4.06e-04 | 119 | 7 | 3 | HP:0001647 | |
| HumanPheno | Inguinal hernia | 4.17e-04 | 312 | 7 | 4 | HP:0000023 | |
| HumanPheno | Abnormal aortic valve cusp morphology | 4.27e-04 | 121 | 7 | 3 | HP:0031567 | |
| HumanPheno | Dural ectasia | 4.40e-04 | 24 | 7 | 2 | HP:0100775 | |
| HumanPheno | Pectus excavatum | 4.77e-04 | 323 | 7 | 4 | HP:0000767 | |
| HumanPheno | Abnormal spinal meningeal morphology | 4.78e-04 | 25 | 7 | 2 | HP:0010303 | |
| HumanPheno | Abnormal periauricular region morphology | 5.39e-04 | 131 | 7 | 3 | HP:0000383 | |
| HumanPheno | Nuclear cataract | 6.02e-04 | 28 | 7 | 2 | HP:0100018 | |
| HumanPheno | Abnormal testis morphology | 6.66e-04 | 1129 | 7 | 6 | HP:0000035 | |
| HumanPheno | Non-obstructive azoospermia | 6.76e-04 | 1132 | 7 | 6 | HP:0011961 | |
| HumanPheno | Small face | 6.84e-04 | 142 | 7 | 3 | HP:0000274 | |
| HumanPheno | Abnormal rectum morphology | 7.27e-04 | 145 | 7 | 3 | HP:0002034 | |
| HumanPheno | Azoospermia | 7.67e-04 | 1157 | 7 | 6 | HP:0000027 | |
| HumanPheno | Colonic diverticula | 7.87e-04 | 32 | 7 | 2 | HP:0002253 | |
| HumanPheno | Abnormal midface morphology | 8.20e-04 | 704 | 7 | 5 | HP:0000309 | |
| HumanPheno | Pulmonary cyst | 8.89e-04 | 34 | 7 | 2 | HP:0032445 | |
| HumanPheno | Abnormal spermatogenesis | 9.02e-04 | 1190 | 7 | 6 | HP:0008669 | |
| HumanPheno | Abnormality of the forehead | 9.83e-04 | 1208 | 7 | 6 | HP:0000290 | |
| HumanPheno | Bladder diverticulum | 9.97e-04 | 36 | 7 | 2 | HP:0000015 | |
| HumanPheno | Bowel diverticulosis | 1.05e-03 | 37 | 7 | 2 | HP:0005222 | |
| HumanPheno | Soft tissue sarcoma | 1.08e-03 | 166 | 7 | 3 | HP:0030448 | |
| HumanPheno | Abnormal sacrum morphology | 1.10e-03 | 167 | 7 | 3 | HP:0005107 | |
| HumanPheno | Abnormal male internal genitalia morphology | 1.16e-03 | 1243 | 7 | 6 | HP:0000022 | |
| HumanPheno | Abnormal neck morphology | 1.22e-03 | 766 | 7 | 5 | HP:0025668 | |
| HumanPheno | Functional abnormality of male internal genitalia | 1.31e-03 | 1269 | 7 | 6 | HP:0000025 | |
| HumanPheno | Chorioretinal atrophy | 1.49e-03 | 44 | 7 | 2 | HP:0000533 | |
| HumanPheno | Abnormal male reproductive system physiology | 1.59e-03 | 1314 | 7 | 6 | HP:0012874 | |
| HumanPheno | Abnormal male external genitalia morphology | 1.70e-03 | 1329 | 7 | 6 | HP:0000032 | |
| HumanPheno | Neoplasm of the nervous system | 1.73e-03 | 195 | 7 | 3 | HP:0004375 | |
| HumanPheno | Abnormality of the outer ear | 1.76e-03 | 1337 | 7 | 6 | HP:0000356 | |
| MousePheno | abnormal eye vasculature morphology | 1.50e-05 | 415 | 12 | 5 | MP:0031346 | |
| MousePheno | abnormal retina blood vessel morphology | 3.41e-05 | 234 | 12 | 4 | MP:0010097 | |
| MousePheno | abnormal enzyme/coenzyme level | 6.33e-05 | 1451 | 12 | 7 | MP:0005319 | |
| MousePheno | abnormal blood vessel morphology | 6.95e-05 | 1472 | 12 | 7 | MP:0001614 | |
| MousePheno | abnormal feces composition | 7.02e-05 | 98 | 12 | 3 | MP:0003868 | |
| MousePheno | herniated abdominal wall | 1.27e-04 | 20 | 12 | 2 | MP:0000757 | |
| MousePheno | abnormal lens morphology | 1.82e-04 | 699 | 12 | 5 | MP:0001303 | |
| MousePheno | abnormal spleen weight | 1.84e-04 | 361 | 12 | 4 | MP:0004951 | |
| MousePheno | abnormal retina vasculature morphology | 2.47e-04 | 390 | 12 | 4 | MP:0002792 | |
| MousePheno | abnormal retina morphology | 2.62e-04 | 1227 | 12 | 6 | MP:0001325 | |
| MousePheno | abnormal ocular fundus morphology | 3.07e-04 | 1262 | 12 | 6 | MP:0002864 | |
| MousePheno | liver degeneration | 3.10e-04 | 31 | 12 | 2 | MP:0003103 | |
| MousePheno | cataract | 6.22e-04 | 497 | 12 | 4 | MP:0001304 | |
| MousePheno | persistence of hyaloid vascular system | 7.92e-04 | 223 | 12 | 3 | MP:0001289 | |
| MousePheno | brain lesion | 8.09e-04 | 50 | 12 | 2 | MP:0021002 | |
| MousePheno | abnormal anterior eye segment morphology | 1.59e-03 | 1117 | 12 | 5 | MP:0005193 | |
| MousePheno | abnormal enzyme/coenzyme activity | 1.64e-03 | 287 | 12 | 3 | MP:0005584 | |
| Domain | Cyt_P450_E_grp-I | 5.24e-08 | 45 | 16 | 4 | IPR002401 | |
| Domain | Cyt_P450_CS | 1.03e-07 | 53 | 16 | 4 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 1.38e-07 | 57 | 16 | 4 | PS00086 | |
| Domain | - | 1.48e-07 | 58 | 16 | 4 | 1.10.630.10 | |
| Domain | p450 | 1.48e-07 | 58 | 16 | 4 | PF00067 | |
| Domain | Cyt_P450 | 1.70e-07 | 60 | 16 | 4 | IPR001128 | |
| Domain | EGF_CA | 5.05e-05 | 86 | 16 | 3 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 7.24e-05 | 97 | 16 | 3 | IPR018097 | |
| Domain | EGF_CA | 7.69e-05 | 99 | 16 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 7.93e-05 | 100 | 16 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.43e-05 | 106 | 16 | 3 | IPR000152 | |
| Domain | EGF_CA | 1.43e-04 | 122 | 16 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.50e-04 | 124 | 16 | 3 | IPR001881 | |
| Domain | cEGF | 2.21e-04 | 26 | 16 | 2 | PF12662 | |
| Domain | cEGF | 2.21e-04 | 26 | 16 | 2 | IPR026823 | |
| Domain | Growth_fac_rcpt_ | 2.96e-04 | 156 | 16 | 3 | IPR009030 | |
| Domain | EGF | 9.76e-04 | 235 | 16 | 3 | SM00181 | |
| Domain | EGF_3 | 9.76e-04 | 235 | 16 | 3 | PS50026 | |
| Domain | EGF-like_dom | 1.15e-03 | 249 | 16 | 3 | IPR000742 | |
| Domain | EGF_1 | 1.23e-03 | 255 | 16 | 3 | PS00022 | |
| Domain | EGF-like_CS | 1.32e-03 | 261 | 16 | 3 | IPR013032 | |
| Domain | EGF_2 | 1.38e-03 | 265 | 16 | 3 | PS01186 | |
| Domain | EGF | 5.09e-03 | 126 | 16 | 2 | PF00008 | |
| Domain | zf-C3HC4 | 1.53e-02 | 223 | 16 | 2 | PF00097 | |
| Pathway | REACTOME_EICOSANOIDS | 1.48e-10 | 12 | 12 | 4 | MM14845 | |
| Pathway | REACTOME_EICOSANOIDS | 1.48e-10 | 12 | 12 | 4 | M27129 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 3.00e-10 | 14 | 12 | 4 | MM15842 | |
| Pathway | REACTOME_FATTY_ACIDS | 4.09e-10 | 15 | 12 | 4 | M27126 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 9.15e-10 | 18 | 12 | 4 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 9.15e-10 | 18 | 12 | 4 | MM14841 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 3.77e-09 | 25 | 12 | 4 | MM14858 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 1.22e-08 | 33 | 12 | 4 | MM15963 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 1.22e-08 | 33 | 12 | 4 | MM15918 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 7.75e-08 | 11 | 12 | 3 | MM14863 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.03e-07 | 12 | 12 | 3 | M27128 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.53e-07 | 61 | 12 | 4 | MM14861 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.64e-07 | 62 | 12 | 4 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.86e-07 | 64 | 12 | 4 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.11e-07 | 66 | 12 | 4 | MM14839 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 6.21e-07 | 21 | 12 | 3 | M27137 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.32e-06 | 104 | 12 | 4 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.37e-06 | 105 | 12 | 4 | MM14842 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 7.98e-06 | 48 | 12 | 3 | MM15902 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 9.37e-06 | 170 | 12 | 4 | MM15573 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.25e-05 | 183 | 12 | 4 | M39588 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.49e-05 | 59 | 12 | 3 | M27140 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 2.38e-05 | 9 | 12 | 2 | M39819 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.54e-05 | 219 | 12 | 4 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.59e-05 | 220 | 12 | 4 | M10320 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX | 2.66e-04 | 29 | 12 | 2 | M39858 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 3.05e-04 | 31 | 12 | 2 | M39851 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 3.87e-04 | 176 | 12 | 3 | M27854 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 1.07e-03 | 58 | 12 | 2 | M5410 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 1.38e-03 | 620 | 12 | 4 | MM15193 | |
| Pubmed | Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11. | 5.02e-14 | 4 | 18 | 4 | 18065749 | |
| Pubmed | 7.53e-13 | 6 | 18 | 4 | 9068972 | ||
| Pubmed | 4.65e-10 | 4 | 18 | 3 | 22665481 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 4.65e-10 | 4 | 18 | 3 | 11185557 | |
| Pubmed | 1.16e-09 | 5 | 18 | 3 | 22969154 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 1.16e-09 | 5 | 18 | 3 | 21466787 | |
| Pubmed | 4.07e-09 | 7 | 18 | 3 | 22160543 | ||
| Pubmed | 4.51e-08 | 70 | 18 | 4 | 15128046 | ||
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 24138531 | ||
| Pubmed | Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies. | 2.53e-07 | 2 | 18 | 2 | 18662666 | |
| Pubmed | 2.53e-07 | 2 | 18 | 2 | 15364545 | ||
| Pubmed | Expression and physiological function of CYP4F subfamily in human eosinophils. | 2.53e-07 | 2 | 18 | 2 | 17980168 | |
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 2.53e-07 | 2 | 18 | 2 | 8026587 | |
| Pubmed | 7.59e-07 | 3 | 18 | 2 | 20472562 | ||
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 7.59e-07 | 3 | 18 | 2 | 15145985 | |
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 1.52e-06 | 44 | 18 | 3 | 12745259 | |
| Pubmed | 1.74e-06 | 46 | 18 | 3 | 25209997 | ||
| Pubmed | Regulation of neuronal survival and morphology by the E3 ubiquitin ligase RNF157. | 2.53e-06 | 5 | 18 | 2 | 25342469 | |
| Pubmed | 2.53e-06 | 5 | 18 | 2 | 18577768 | ||
| Pubmed | A Membrane-Tethered Ubiquitination Pathway Regulates Hedgehog Signaling and Heart Development. | 2.53e-06 | 5 | 18 | 2 | 32966817 | |
| Pubmed | 7.99e-06 | 76 | 18 | 3 | 22323595 | ||
| Pubmed | 1.67e-04 | 37 | 18 | 2 | 19266077 | ||
| Pubmed | 1.76e-04 | 38 | 18 | 2 | 20805985 | ||
| Pubmed | 3.83e-04 | 56 | 18 | 2 | 19591821 | ||
| Pubmed | 4.01e-04 | 284 | 18 | 3 | 15057824 | ||
| Interaction | ATRN interactions | 1.52e-05 | 55 | 18 | 3 | int:ATRN | |
| Interaction | LTBP1 interactions | 7.15e-05 | 92 | 18 | 3 | int:LTBP1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.11e-05 | 797 | 18 | 5 | chr19p13 | |
| Cytoband | 19p13.1 | 1.62e-04 | 48 | 18 | 2 | 19p13.1 | |
| Cytoband | 12q13.3 | 1.83e-04 | 51 | 18 | 2 | 12q13.3 | |
| Cytoband | 8p23.1 | 1.65e-03 | 154 | 18 | 2 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 3.75e-03 | 234 | 18 | 2 | chr8p23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 1.18e-02 | 423 | 18 | 2 | chr12q13 | |
| GeneFamily | Cytochrome P450 family 4 | 1.31e-08 | 36 | 14 | 4 | 1003 | |
| GeneFamily | Ring finger proteins | 1.86e-02 | 275 | 14 | 2 | 58 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 2.11e-07 | 20 | 16 | 3 | MM1104 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_DN | 1.38e-05 | 78 | 16 | 3 | M9911 | |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN | 1.93e-05 | 274 | 16 | 4 | M289 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 3.98e-05 | 330 | 16 | 4 | MM1120 | |
| Coexpression | CTIP_DN.V1_DN | 6.97e-05 | 134 | 16 | 3 | M2751 | |
| Coexpression | WANG_TNF_TARGETS | 1.13e-04 | 26 | 16 | 2 | M2308 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 1.22e-04 | 27 | 16 | 2 | MM1135 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 1.22e-04 | 27 | 16 | 2 | M1391 | |
| Coexpression | GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP | 1.36e-04 | 168 | 16 | 3 | M8665 | |
| Coexpression | BOCHKIS_FOXA2_TARGETS | 1.53e-04 | 467 | 16 | 4 | MM1233 | |
| Coexpression | NFE2L2.V2 | 1.55e-04 | 469 | 16 | 4 | M2870 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN | 1.64e-04 | 179 | 16 | 3 | M16932 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_DN | 1.96e-04 | 190 | 16 | 3 | MM1311 | |
| Coexpression | GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 2.15e-04 | 196 | 16 | 3 | M5349 | |
| Coexpression | GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 2.18e-04 | 197 | 16 | 3 | M5351 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP | 2.18e-04 | 197 | 16 | 3 | M4993 | |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN | 2.24e-04 | 199 | 16 | 3 | M2921 | |
| Coexpression | GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN | 2.28e-04 | 200 | 16 | 3 | M6193 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 2.41e-04 | 204 | 16 | 3 | MM17090 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | 3.21e-04 | 567 | 16 | 4 | M16909 | |
| Coexpression | BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES | 4.86e-04 | 259 | 16 | 3 | M40029 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-06 | 197 | 18 | 4 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-06 | 197 | 18 | 4 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-06 | 197 | 18 | 4 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.21e-05 | 156 | 18 | 3 | bcc862d2eb018680fec7e7196704eb285361501f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-05 | 168 | 18 | 3 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-05 | 171 | 18 | 3 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.45e-05 | 174 | 18 | 3 | 53c2c132566a7682f3268c7f9138700f09c3b94d | |
| ToppCell | droplet-Heart-nan-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-05 | 174 | 18 | 3 | cf4e0567f2a4ebe5534046b1c091af59b55bdc4f | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-05 | 185 | 18 | 3 | eaa54b76743628c89b4310be57b87fa92b75fd37 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-05 | 185 | 18 | 3 | f7f4c921d248c637351e2e882589b99ba7f04b66 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-05 | 185 | 18 | 3 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-05 | 185 | 18 | 3 | ff38a15af3dec36d9993f06623591872b5d1da9a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-05 | 185 | 18 | 3 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 191 | 18 | 3 | 1efb47743b6834b64cb0f61721ddbe875b1a66ca | |
| ToppCell | droplet-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.96e-05 | 192 | 18 | 3 | 086b47f87283cd41139cd56686011f8b5821b0da | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.96e-05 | 192 | 18 | 3 | fee99ca7e658963acf968aa724ef8c96cfc00a5d | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.05e-05 | 193 | 18 | 3 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 194 | 18 | 3 | 20a0439fa02c5f8107612e34c7ab54120b9b8573 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.14e-05 | 194 | 18 | 3 | 7b6ec45adb7ece3c8a7b78c5782413b5825effe2 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 195 | 18 | 3 | 9ffabd831c2a0de3597f328e83db7ee259cb0ccc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.24e-05 | 195 | 18 | 3 | 24d226f89dd337c22728688e4b40ca082a0e1fe1 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 195 | 18 | 3 | 613bea20c3d82c22a6af4c1a668af6fcf11fec0a | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 196 | 18 | 3 | 1eb14182ef26e6141f510d397b00bf8a12efda3e | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 196 | 18 | 3 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-05 | 196 | 18 | 3 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.33e-05 | 196 | 18 | 3 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.52e-05 | 198 | 18 | 3 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.52e-05 | 198 | 18 | 3 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.52e-05 | 198 | 18 | 3 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.62e-05 | 199 | 18 | 3 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.62e-05 | 199 | 18 | 3 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.62e-05 | 199 | 18 | 3 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.62e-05 | 199 | 18 | 3 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.72e-05 | 200 | 18 | 3 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.72e-05 | 200 | 18 | 3 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 6.72e-05 | 200 | 18 | 3 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.72e-05 | 200 | 18 | 3 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Esophagus_Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 6.33e-04 | 93 | 18 | 2 | 4ab8c28f7c47129ac633bcfdc7ccc8f7793464d5 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.52e-04 | 108 | 18 | 2 | c647f6595e7cccea91429a2377c9de6cc1acff4d | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.05e-03 | 120 | 18 | 2 | a320799ab5f2ce872e038b15841a23174c5436e8 | |
| ToppCell | Control-Neutrophil|Control / Disease condition and Cell class | 1.16e-03 | 126 | 18 | 2 | 450c01d89714feee6529680ec3ce69067a54b37c | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-03 | 126 | 18 | 2 | 730fc6dc740613b55e40e85334fa30330aa81c3b | |
| ToppCell | Control-Neutrophil-|Control / Disease condition and Cell class | 1.16e-03 | 126 | 18 | 2 | 65fff5ec2296272e94f44546606587833191dd82 | |
| ToppCell | Control-Myeloid_G-Neutrophil|Control / Disease group, lineage and cell class | 1.17e-03 | 127 | 18 | 2 | d4af23d621b546785a077c367c3a66c59749fc15 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-03 | 129 | 18 | 2 | 5578a9ef85706ab6a204ff31716e781ec3893b75 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.21e-03 | 129 | 18 | 2 | 13cd10ffdd8f1ef7721884e9efd2cf25f170f414 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-03 | 130 | 18 | 2 | 124f76067a2d4448ce06158a769d0d11b0297110 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-03 | 130 | 18 | 2 | cd6d8d646345b01ff0f04f776330a05b82e63bc9 | |
| ToppCell | Control-Myeloid_G|Control / Disease group, lineage and cell class | 1.25e-03 | 131 | 18 | 2 | d5a53431f1f1b283fb9338b8561e6381f0227c62 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.31e-03 | 134 | 18 | 2 | 7b237690a3765d974f6f813ef2d01154bc23b9d6 | |
| ToppCell | COVID-19_Mild-Myeloid_G-Neutrophil|COVID-19_Mild / Disease group, lineage and cell class | 1.32e-03 | 135 | 18 | 2 | e9eb2bebb6d19c439c83f46c12ca0d676db69de8 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.36e-03 | 137 | 18 | 2 | 9324b55eac55e0cc1e8e450a4b5374d12e9587a3 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.36e-03 | 137 | 18 | 2 | 032f8409d0d179e254c8ff632afbda78852a9889 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.36e-03 | 137 | 18 | 2 | 265a4a50e48b13c8b3b0730f818235f71fbd6baa | |
| ToppCell | Club_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.38e-03 | 138 | 18 | 2 | 133015953fc660d00339f47b415da5e9872313a2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.46e-03 | 142 | 18 | 2 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | COVID-19_Mild-Myeloid_G|COVID-19_Mild / Disease group, lineage and cell class | 1.46e-03 | 142 | 18 | 2 | c8aeb747ed836197265d269aa131fae172b45aec | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.48e-03 | 143 | 18 | 2 | 974260c25dad599eea83a33e83117f7307b92a42 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.48e-03 | 143 | 18 | 2 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.51e-03 | 144 | 18 | 2 | b638398f559e7fd9d4294d1c830beeb20f905960 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-03 | 145 | 18 | 2 | 07acbf086cffce0628accf078d31bf190f803988 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-03 | 149 | 18 | 2 | defe2e4a2f3118f8b42e99a4f2bf03e54c1b698f | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.65e-03 | 151 | 18 | 2 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-03 | 152 | 18 | 2 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-03 | 152 | 18 | 2 | 3a1414ba6a4972698c3262a00b124428835c35cb | |
| ToppCell | 368C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.67e-03 | 152 | 18 | 2 | ee7855d76a49d07a032677a4dc83aa6116d50518 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-03 | 152 | 18 | 2 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-03 | 154 | 18 | 2 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.72e-03 | 154 | 18 | 2 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-03 | 154 | 18 | 2 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.72e-03 | 154 | 18 | 2 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.72e-03 | 154 | 18 | 2 | a2adaa4a6cd8708cd579b8efbeb4ff2131c5482e | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.72e-03 | 154 | 18 | 2 | b5604c0b0b9b283352a3f612f40883b9123475d1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.72e-03 | 154 | 18 | 2 | 160b170a3ade8b246843c9854af332475c047ba0 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.76e-03 | 156 | 18 | 2 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-03 | 156 | 18 | 2 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-03 | 157 | 18 | 2 | c779a53b2c67d566f5d417e753cd17196a6bfd1c | |
| ToppCell | severe_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 1.81e-03 | 158 | 18 | 2 | 8ab3d8a9b7a1daa890d76dde1d6182af40b70021 | |
| ToppCell | severe_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 1.81e-03 | 158 | 18 | 2 | ff3fa4bd06e01363429aec4bb587b95819bf0fc9 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-03 | 159 | 18 | 2 | 2fb1d2ff52920aeb48d048cf29f0cd45f944a73d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-03 | 160 | 18 | 2 | 928d942b9f611fd4bd2faa660bf2809278495f23 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.85e-03 | 160 | 18 | 2 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-03 | 161 | 18 | 2 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 1.88e-03 | 161 | 18 | 2 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L5_RORB_SNHG7|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.90e-03 | 162 | 18 | 2 | daacccf8b1374680803f49135673a00e09691cde | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.90e-03 | 162 | 18 | 2 | 112fa4de685727f6c8bf6fc4afb82de0524070ad | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.92e-03 | 163 | 18 | 2 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-03 | 163 | 18 | 2 | 1c014e373667be290d7fb5d24c06c6f313ac8fa3 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.94e-03 | 164 | 18 | 2 | 81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-03 | 165 | 18 | 2 | cca3ba9d7d30404e3e683b8cfd500c348a4974b9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-03 | 166 | 18 | 2 | d96c562e1483adb4cdd817b68133f03356d7279b | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-03 | 167 | 18 | 2 | 3e3d8f6df2feefafad5b44ba0ebf5b5a0fe4ed58 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-03 | 167 | 18 | 2 | 3ad9f3122dbe96580f640388ef920ea209fc2349 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-03 | 167 | 18 | 2 | 5c0ede7783403f1c8004cf8c45785687e89046c6 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 2.04e-03 | 168 | 18 | 2 | 8ade4d098aeecda2d80c1cad1cebe9a063eae948 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-03 | 168 | 18 | 2 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 168 | 18 | 2 | 29a6c3ba69e03ccb19efb8ac177b9a162dc1ea43 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.04e-03 | 168 | 18 | 2 | 04259f5a9b067cd1b5619e34591e4b2fccc18535 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 168 | 18 | 2 | 4297be958a4754677df7cf73feba19b0d76f1b4a | |
| Computational | Neighborhood of GSTM1 | 2.09e-04 | 109 | 12 | 3 | GNF2_GSTM1 | |
| Computational | Neighborhood of LCAT | 3.06e-04 | 124 | 12 | 3 | GNF2_LCAT | |
| Computational | Neighborhood of HPN | 3.84e-04 | 134 | 12 | 3 | GNF2_HPN | |
| Computational | Neighborhood of HPX | 3.92e-04 | 135 | 12 | 3 | GNF2_HPX | |
| Drug | dichloran | 1.62e-08 | 41 | 16 | 4 | CID000007430 | |
| Drug | propoxyphene | 1.21e-07 | 67 | 16 | 4 | CID000010100 | |
| Drug | carteolol | 1.63e-07 | 72 | 16 | 4 | CID000002583 | |
| Drug | trimipramine | 2.49e-07 | 80 | 16 | 4 | CID000005584 | |
| Drug | diosmetin | 3.18e-07 | 85 | 16 | 4 | CID005281612 | |
| Drug | mephenytoin | 3.66e-07 | 88 | 16 | 4 | CID000004060 | |
| Drug | tienilic acid | 4.57e-07 | 93 | 16 | 4 | CID000038409 | |
| Drug | lansoprazole | 4.57e-07 | 93 | 16 | 4 | CID000003883 | |
| Drug | AC1L1KIN | 6.12e-07 | 100 | 16 | 4 | CID000005516 | |
| Drug | Sparteinum | 6.37e-07 | 101 | 16 | 4 | CID000003966 | |
| Drug | ebastine | 6.49e-07 | 25 | 16 | 3 | CID000003191 | |
| Drug | AC1Q7AUJ | 1.15e-06 | 117 | 16 | 4 | CID000003303 | |
| Drug | 8-MOP | 1.19e-06 | 118 | 16 | 4 | CID000004114 | |
| Drug | hexobarbital | 1.60e-06 | 127 | 16 | 4 | CID000003608 | |
| Drug | chloral hydrate | 1.70e-06 | 129 | 16 | 4 | CID000002707 | |
| Drug | aminoglutethimide | 2.16e-06 | 137 | 16 | 4 | CID000002145 | |
| Drug | AC1O5PIQ | 2.56e-06 | 39 | 16 | 3 | CID006438348 | |
| Drug | paraoxon | 4.41e-06 | 164 | 16 | 4 | CID000009395 | |
| Drug | felodipine | 4.97e-06 | 169 | 16 | 4 | CID000003333 | |
| Drug | aminopyrine | 5.21e-06 | 171 | 16 | 4 | CID000006009 | |
| Drug | metyrapone | 6.25e-06 | 179 | 16 | 4 | CID000004174 | |
| Drug | alprazolam | 8.41e-06 | 193 | 16 | 4 | CID000002118 | |
| Drug | Fluorometholone [426-13-1]; Up 200; 10.6uM; PC3; HT_HG-U133A | 8.94e-06 | 196 | 16 | 4 | 5771_UP | |
| Drug | tolbutamide | 9.30e-06 | 198 | 16 | 4 | CID000005505 | |
| Drug | 17-ODYA | 9.51e-06 | 60 | 16 | 3 | CID000001449 | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 9.68e-06 | 200 | 16 | 4 | 7156_UP | |
| Drug | 3-hydroxystearate | 9.70e-06 | 7 | 16 | 2 | CID005282907 | |
| Drug | diclofenac | 1.15e-05 | 209 | 16 | 4 | CID000003032 | |
| Drug | 2,2,2-trichloroethanol | 1.72e-05 | 73 | 16 | 3 | CID000008259 | |
| Drug | 3 -hydroxypregn-5-en-20-one | 1.92e-05 | 238 | 16 | 4 | CID000001027 | |
| Drug | 18-HETE | 2.08e-05 | 10 | 16 | 2 | CID006442778 | |
| Drug | 6-trans-leukotriene B4 | 2.22e-05 | 247 | 16 | 4 | CID000000169 | |
| Drug | 2-naphthol | 3.55e-05 | 93 | 16 | 3 | CID000008663 | |
| Drug | 3-hydroxyhexadecanoic acid | 3.60e-05 | 13 | 16 | 2 | CID000301590 | |
| Drug | azo analog I | 3.60e-05 | 13 | 16 | 2 | CID006438575 | |
| Drug | 7-BFC | 4.19e-05 | 14 | 16 | 2 | CID000848780 | |
| Drug | diamidine | 4.84e-05 | 15 | 16 | 2 | CID000008813 | |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 4.97e-05 | 104 | 16 | 3 | ctd:C000595015 | |
| Drug | rifampicin | 5.13e-05 | 306 | 16 | 4 | CID005381226 | |
| Drug | 20-HETE | 5.26e-05 | 106 | 16 | 3 | CID005283157 | |
| Drug | clofibrate | 5.46e-05 | 311 | 16 | 4 | CID000002796 | |
| Drug | halothane | 5.67e-05 | 314 | 16 | 4 | CID000003562 | |
| Drug | AC1L1AL2 | 6.70e-05 | 115 | 16 | 3 | CID000001035 | |
| Drug | pleuromutilin | 7.04e-05 | 18 | 16 | 2 | CID000031326 | |
| Drug | Azamulinum | 7.04e-05 | 18 | 16 | 2 | CID003086060 | |
| Drug | benzphetamine | 7.42e-05 | 119 | 16 | 3 | CID000002341 | |
| Drug | DB75 | 7.86e-05 | 19 | 16 | 2 | CID000126437 | |
| Drug | deferoxamine | 7.98e-05 | 343 | 16 | 4 | CID000002973 | |
| Drug | dioxin | 8.35e-05 | 347 | 16 | 4 | CID000015625 | |
| Drug | 2-nitroimidazole | 9.43e-05 | 129 | 16 | 3 | CID000010701 | |
| Drug | phenobarbital | 9.63e-05 | 360 | 16 | 4 | CID000004763 | |
| Drug | 20-hydroxyleukotriene B4 | 1.49e-04 | 26 | 16 | 2 | CID000001589 | |
| Drug | C14845 | 1.61e-04 | 27 | 16 | 2 | CID011954064 | |
| Drug | BP-9,10-oxide | 1.61e-04 | 27 | 16 | 2 | CID000037456 | |
| Drug | Brn 4136738 | 1.61e-04 | 27 | 16 | 2 | CID000050331 | |
| Drug | nifedipine | 1.66e-04 | 415 | 16 | 4 | CID000004485 | |
| Drug | 9-OH-BaP-4,5-oxide | 1.73e-04 | 28 | 16 | 2 | CID000115064 | |
| Drug | 11-H-14,15-EETA | 1.99e-04 | 30 | 16 | 2 | CID011954058 | |
| Drug | 19-hydroxytestosterone | 1.99e-04 | 30 | 16 | 2 | CID000150968 | |
| Drug | melatonin | 2.14e-04 | 443 | 16 | 4 | CID000000896 | |
| Drug | BP-7,8-oxide | 2.27e-04 | 32 | 16 | 2 | CID000037455 | |
| Drug | K-K-K | 2.32e-04 | 175 | 16 | 3 | CID000003823 | |
| Drug | TCEO | 2.56e-04 | 34 | 16 | 2 | CID000028167 | |
| Drug | 12(13)-EpOME | 2.56e-04 | 34 | 16 | 2 | CID000001416 | |
| Drug | AC1O5XSP | 2.56e-04 | 34 | 16 | 2 | CID006442739 | |
| Drug | AC1L1CJI | 2.72e-04 | 35 | 16 | 2 | CID000001929 | |
| Drug | NSC98537 | 2.74e-04 | 473 | 16 | 4 | CID000005410 | |
| Drug | celastrol; Down 200; 2.5uM; MCF7; HT_HG-U133A_EA | 2.82e-04 | 187 | 16 | 3 | 887_DN | |
| Drug | 15-H-11,12-EETA | 2.88e-04 | 36 | 16 | 2 | CID011954042 | |
| Drug | AC1L3NGJ | 2.88e-04 | 36 | 16 | 2 | CID000092121 | |
| Drug | lauric acid | 3.10e-04 | 193 | 16 | 3 | CID000003893 | |
| Drug | 5114445; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.10e-04 | 193 | 16 | 3 | 901_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 3732_DN | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.24e-04 | 196 | 16 | 3 | 4655_DN | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 5083_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 6663_DN | |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 6759_UP | |
| Drug | Aminocaproic acid [60-32-2]; Up 200; 30.4uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 7258_UP | |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 5106_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.34e-04 | 198 | 16 | 3 | 1061_DN | |
| Drug | Triamterene [396-01-0]; Up 200; 15.8uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 7307_UP | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 6742_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 5621_DN | |
| Drug | Dacarbazine [4342-03-4]; Up 200; 22uM; MCF7; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 2754_UP | |
| Drug | oxygen | 3.36e-04 | 499 | 16 | 4 | CID000000977 | |
| Drug | 11,14,15-THET | 3.38e-04 | 39 | 16 | 2 | CID006439531 | |
| Drug | Kanamycin A sulfate [25389-94-0]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 5686_UP | |
| Drug | Benzylpenicillin sodium [69-57-8]; Up 200; 11.2uM; HL60; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 6155_UP | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 4115_UP | |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 7246_UP | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 2057_DN | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; PC3; HT_HG-U133A | 3.44e-04 | 200 | 16 | 3 | 4075_DN | |
| Drug | AC1L1HMM | 3.82e-04 | 516 | 16 | 4 | CID000004196 | |
| Drug | 11,12,15-trihydroxyeicosatrienoic acid | 3.92e-04 | 42 | 16 | 2 | CID006439610 | |
| Drug | NADP(H | 4.14e-04 | 527 | 16 | 4 | CID000000930 | |
| Drug | naphthalene-1,2-dihydrodiol | 4.50e-04 | 45 | 16 | 2 | CID000000362 | |
| Drug | C14802 | 4.91e-04 | 47 | 16 | 2 | CID011954053 | |
| Drug | Furan | 4.91e-04 | 47 | 16 | 2 | CID000008029 | |
| Drug | C14800 | 5.13e-04 | 48 | 16 | 2 | CID011954051 | |
| Drug | nitro-L | 5.13e-04 | 48 | 16 | 2 | CID000006849 | |
| Disease | hexadecenedioate (C16:1-DC) measurement | 9.90e-06 | 9 | 16 | 2 | EFO_0800562 | |
| Disease | Migraine Disorders | 2.14e-05 | 13 | 16 | 2 | C0149931 | |
| Disease | colon carcinoma | 8.89e-05 | 26 | 16 | 2 | EFO_1001950 | |
| Disease | hypertension (biomarker_via_orthology) | 2.34e-04 | 227 | 16 | 3 | DOID:10763 (biomarker_via_orthology) | |
| Disease | aortic measurement | 3.14e-04 | 251 | 16 | 3 | EFO_0020865 | |
| Disease | pulse pressure measurement | 6.55e-04 | 1392 | 16 | 5 | EFO_0005763 | |
| Disease | migraine disorder, Headache | 9.81e-04 | 86 | 16 | 2 | HP_0002315, MONDO_0005277 | |
| Disease | descending aortic diameter | 1.03e-03 | 88 | 16 | 2 | EFO_0021788 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 1.99e-03 | 123 | 16 | 2 | EFO_0007789, EFO_0008002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CLRDSYPRPDQPCYL | 756 | Q9UPY3 | |
| ARFVCPPNRPFRCKN | 3691 | Q07954 | |
| LRYQANNCPICRLPF | 306 | O60291 | |
| RPAPLAPFFRCACAQ | 1351 | Q9UM47 | |
| FYDNCRRLQCFPQPP | 41 | Q9HBI6 | |
| FYNNCRRLQCFPQPP | 41 | Q9HCS2 | |
| FYDNCRRLRCFPQPP | 41 | P78329 | |
| FYDNCCRLRCFPQPP | 41 | Q08477 | |
| FPPPPFYLNCDTRRN | 4946 | Q8NDH2 | |
| RCRAAFPQCYPLPPT | 206 | E9PI22 | |
| GFRCYPRNPCQDPYI | 356 | Q12805 | |
| RYQANNCPICRLPFR | 306 | Q96PX1 | |
| RCRAAFPQCYPLPPT | 206 | P0DMB1 | |
| ERPFPCPQCGRAYTL | 576 | Q9H9D4 | |
| YCNLVDLRRCPRSPP | 191 | Q9BRR9 | |
| PFRRFMNRFQCPFCP | 431 | Q96JM2 | |
| FPYPQDCNPRCPMRC | 151 | O43692 | |
| LNVRGFLDRYCPPNC | 561 | P53667 |